Trials / Completed
CompletedNCT03738449
The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 Under Fed Condition in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-387 and D484 under fed condition in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-387 | Test drug |
| DRUG | D484 | reference drug |
Timeline
- Start date
- 2019-01-08
- Primary completion
- 2019-01-18
- Completion
- 2019-01-24
- First posted
- 2018-11-13
- Last updated
- 2019-02-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03738449. Inclusion in this directory is not an endorsement.